BioStock: BrainCool wants to reform stroke care

After attracting a lot of attention for its EU-funded stroke study, BrainCool has now launched a new strategy to target stroke as a new medical indication for RhinoChill. In an interview with BioStock, CEO Martin Waleij says that it would mean a paradigm shift for stroke care.

Read the full interview with Martin Waleij at biostock.se:

https://www.biostock.se/en/2023/03/braincool-wants-to-reform-stroke-care/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/